Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-25
2011-01-25
Lucas, Zachariah (Department: 1648)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C536S017200, C536S017300, C536S018700, C536S026700, C536S017500
Reexamination Certificate
active
07875604
ABSTRACT:
The present invention describes novel methods of identifying compounds which inhibit HIV particle formation and Rev-dependent HIV production. The present invention also provides methods and compounds for inhibiting HIV particle formation and or treating patients infected with HIV.
REFERENCES:
Gait et al. Progress in anti-HIV structure-based drug design. Trends in Biotechnology Oct. 1995, vol. 13, No. 10, p. 430-438.
Hendrix et al. Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers. Antimicrobial Agents and Chemotherapy, Jun. 2000, vol. 44, No. 6, p. 1667-1673.
Buss et al. Measuring the effectiveness of antiretroviral agents. Antiviral Therapy 2001, vol. 6, pp. 1-7.
Yin et al. Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance. Cellular and Molecular Life Sciences Aug. 2006, vol. 63(15), p. 1706-1724.
Lee et al. Toxicity of Nucleoside Analogues Used to Treat AIDS and the Selectivity of the Mitochondrial DNA Polymerase. Biochemistry 2003, vol. 42, No. 50, p. 14711-14719.
Greene et al. Novel targets for HIV therapy. Antiviral Research 2008, vol. 80, p. 251-265.
Olszewski et al. Guanidine alkaloid analogs as inhibitors of HIV-1 Nef interactions with p53, actin, and p56. The Proceedings from the National Academy of Science, U.S.A Sep. 2004, vol. 101, No. 39, pp. 14079-14084.
Hammarskjöld Marie-Louise
Rekosh David
Humphrey Louise
Lucas Zachariah
Sparks Rodney L.
University of Virginia Patent Foundation
LandOfFree
Compounds that inhibit HIV particle formation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds that inhibit HIV particle formation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds that inhibit HIV particle formation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2696118